104 Health Systems Ranked by Annual Revenue

Why It Matters

The data underscores how scale, strategic M&A, and diversified ambulatory services are becoming decisive factors for financial performance in the hospital sector, shaping investor outlooks and policy discussions.

Key Takeaways

• Kaiser Permanente leads with $127.7 B revenue
• HCA Healthcare ranks second at $75.6 B
• Double‑digit revenue gains driven by mergers and payer deals
• Smaller systems under $1 B face consolidation pressure
• Ambulatory and pharmacy expansions boost top‑line growth

Pulse Analysis

The 2025 revenue rankings reveal a health‑care landscape increasingly dominated by a handful of mega‑systems. Kaiser Permanente’s $127.7 billion top line reflects its integrated model that combines insurance, hospital, and outpatient services, allowing it to capture a larger share of patient spending. HCA Healthcare and CommonSpirit follow, illustrating how for‑profit and nonprofit giants alike leverage scale to negotiate better payer rates and invest in high‑margin ambulatory sites. This concentration is reshaping market dynamics, with the top five systems accounting for roughly 45% of total reported revenue.

Mergers and acquisitions remain a primary engine of growth. Systems that posted double‑digit revenue increases—such as those completing cross‑regional consolidations or securing new payer contracts—demonstrated the financial upside of expanding network footprints. Conversely, health systems that divested hospitals or restructured portfolios often saw flat or declining revenues, highlighting the risk of operating at a smaller scale in a competitive environment. The trend toward vertical integration, especially the addition of pharmacy and outpatient clinics, is helping larger players diversify income streams and offset pressures on inpatient margins.

For investors and policymakers, the ranking signals where capital is likely to flow in the coming years. Large, diversified systems with robust ambulatory operations are better positioned to weather reimbursement changes and labor shortages, making them attractive targets for private equity and public market investors. Meanwhile, smaller systems may pursue strategic alliances or be absorbed by larger entities to achieve economies of scale. Understanding these revenue patterns is essential for stakeholders aiming to navigate the evolving economics of U.S. health care.